HomeFilePeripheral vascular disease

Peripheral vascular disease

View Category

Carotid

Asymptomatic Carotid Artery Stenosis: Do We Have All the Answers?

Advancements in therapies to reduce the impact of stroke in asymptomatic carotid artery stenosis have been hard...
solaci -
Learn More
Carotid

The Whole Toolkit Tested in Carotid Artery Stenting

This study sought to randomly compare the double-layer Roadsaver stent (Terumo) with the single-layer Carotid Wallstent device...
solaci -
Learn More
Coronary disease

Prolonged Exposure to Pollution Increases the Risk for Cardiovascular Disease

In the midst of the COVID-19 pandemic, it is hard to think of anything else that might...
solaci -
Learn More
Coronary disease

ECS Guidelines for COVID-19 Management

One of the first statements in this document points out these are not “regular guidelines” developed after...
solaci -
Learn More
Coronary disease

Cardiology in Times of Coronavirus: The Perfect Storm

Since January 2020, the COVID-19 infection has spread from China to the rest of the world. The...
solaci -
Learn More
Peripheral vascular disease

Virtual ACC 2020 | Renal Denervation Arises with New Evidence

In patients with uncontrolled hypertension who do not comply with treatment, renal denervation can generate benefit by...
solaci -
Learn More
Antithrombotic Anticoagulants

Virtual ACC 2020 | VOYAGER PAD: Rivaroxaban Superior to Aspirin in Preventing Events

In patients with peripheral artery disease undergoing revascularization, the combination of rivaroxaban (Xarelto) and low doses of...
solaci -
Learn More
Antithrombotic Anticoagulants

Virtual ACC 2020 | COMPASS Sub-Analysis: Diabetes Increases the Benefit of Rivaroxaban Combined with AAS

In patients with stable coronary or peripheral artery disease, diabetes increases the benefit of combining low doses...
solaci -
Learn More